REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 209 filers reported holding REATA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.53 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $544 | -99.9% | 14,327 | -57.4% | 0.01% | -27.3% |
| Q3 2022 | $844,000 | -77.2% | 33,594 | -72.4% | 0.01% | -75.6% |
| Q2 2022 | $3,700,000 | +661.3% | 121,750 | +721.4% | 0.04% | +650.0% |
| Q1 2022 | $486,000 | -71.9% | 14,823 | -77.4% | 0.01% | -66.7% |
| Q4 2021 | $1,729,000 | -21.6% | 65,558 | +196.3% | 0.02% | -43.8% |
| Q1 2021 | $2,206,000 | +216.0% | 22,123 | +292.0% | 0.03% | +357.1% |
| Q4 2020 | $698,000 | -70.8% | 5,644 | -63.1% | 0.01% | -88.7% |
| Q2 2020 | $2,387,000 | +277.7% | 15,298 | +249.3% | 0.06% | +77.1% |
| Q1 2020 | $632,000 | -59.6% | 4,379 | -42.7% | 0.04% | +20.7% |
| Q4 2019 | $1,563,000 | +548.5% | 7,647 | +154.9% | 0.03% | +262.5% |
| Q3 2019 | $241,000 | – | 3,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |